News Author: Patrice Wendling Publish date: May 17, 2015
WASHINGTON – A simple dietary challenge may help identify nonceliac gluten sensitivity in patients with gastrointestinal functional disorders, results...
Video Author: Patrice Wendling Publish date: May 17, 2015
WASHINGTON – Your patient has cirrhosis, platelets 60,000 mm3, an INR of 2.0, serum creatinine of 1.2 mg/dL, and requires an endoscopic retrograde cho...
News Author: Patrice Wendling Publish date: May 10, 2015
Key clinical point: HPV vaccination provided strong protection at multiple anatomic sites in women without prior HPV exposure, and may still offer...
News Author: Patrice Wendling Publish date: May 10, 2015
Key clinical point: Adult survivors of childhood burn injuries have increased rates of Axis I mental and physical disorders.
Major finding: 81% of...
News Author: Patrice Wendling Publish date: May 9, 2015
Key clinical point: Rehabilitation time was associated with reduced risk of scar contracture and lost range of motion in burn patients.
Major find...
News Author: Patrice Wendling Publish date: May 8, 2015
Key clinical point: Weight loss is a strong independent predictor of death in rheumatoid arthritis.
Major finding: Weight loss of more than 3 kg/m...
News Author: Patrice Wendling Publish date: May 5, 2015
Key clinical point: IMCgp100 is clinically active in advanced melanoma, including ocular melanoma and patients refractory to immunotherapy.
Major ...
News Author: Patrice Wendling Publish date: May 1, 2015
News Author: Patrice Wendling Publish date: April 30, 2015
Key clinical point: Combining the PARP inhibitor olaparib and the investigational P13K inhibitor BKM 120 is safe and active in triple-negative bre...
News Author: Patrice Wendling Publish date: April 29, 2015
Key clinical point: Genomic defects, most commonly in BRCA2 and ATM, were associated with olaparib response in metastatic castration-resistant pro...
News Author: Patrice Wendling Publish date: April 23, 2015
Key clinical point: Remote ischemic conditioning prior to CABG did not improve outcomes at 1 year.
Major finding: Cardiovascular death, MI, stroke...
News Author: Patrice Wendling Publish date: April 23, 2015
Key clinical point: Pembrolizumab provided durable responses in NSCLC, with clinical outcomes correlating with a proposed biomarker.
Major finding...
News Author: Patrice Wendling Publish date: April 23, 2015
Key clinical point: In experienced hands, transulnar access is a good alternative default approach for coronary angiography or angioplasty.
Major ...
News Author: Patrice Wendling Publish date: April 23, 2015
News Author: Patrice Wendling Publish date: April 22, 2015
Key clinical point: Metformin use may not improve pancreatic cancer survival.
Major finding: Median survival was 8.1 months without metformin vs.<...
